BMRN vs GEL · P/E 40, rev $1.76B vs rev $978.5M
Biomarin Pharmaceutical Inc (BMRN) versus Genesis Energy LP (GEL) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Genesis Energy LP (GEL) is a oil & gas midstream company listed on NYSE.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported GEL revenue for 2026-06-30 was $978.5M. Net income was $49.7M. GEL currently screens at market cap $1.74B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GEL currently screens at market cap $1.74B.
Not investment advice. Open the BMRN and GEL stock pages for the full models.
Not investment advice.